Results
N atural killer (NK) cells are critical mediators of host immunity against malignancies and viral infection 1 . Although extrinsic regulators of NK cell development and function, including diverse ligands of key NK cell receptors and pro-inflammatory cytokines from the microenvironment have been identified [2] [3] [4] , we understand relatively little about how NK cells translate these signals into critical effector functions 5, 6 . Furthermore, new features of NK cells have emerged in recent years, including their ability to undergo clonal proliferation and generate long-lived memory; however, the molecular mechanisms underlying these 'adaptive' properties require further characterization. The emerging interest in developing NK cell-based cancer immunotherapy 7 and new vaccine strategies for controlling lethal infectious diseases highlights an urgent need for identifying new intrinsic regulators of NK cellmediated immunity.
The activation of endoplasmic reticulum (ER) stress sensor inositol-requiring enzyme 1 (IRE1α) and its substrate transcription factor X-box-binding protein 1 (XBP1) 8, 9 is a hallmark of 'professional' secretory cells that must constitutively deal with a high demand for protein synthesis, folding and secretion [10] [11] [12] . This highly evolutionarily conserved signaling pathway is also activated in tumor cells 13 and in myeloid-derived suppressor cells 14 , macrophages 15 , T cells 16 and dendritic cells 17 in response to external stimuli such as hypoxia, nutrient deprivation and low pH. However, it is unknown whether NK cell function is driven by IRE1α-XBP1 signaling, and if so, what specific activities it controls.
To address these questions, we used an IRE1α activation reporter mouse strain to demonstrate that activated NK cells upregulate the IRE1α-XBP1 pathway following exposure to pro-inflammatory cytokines in vitro and to viral infection in vivo. We use newly engineered genetic mouse models to identify the IRE1α-XBP1 pathway as a positive cell-intrinsic regulator of NK cell proliferation and expansion during viral infection or lymphopenia and of NK cell-mediated antitumor protection. IRE1α-XBP1 is induced by the mammalian target of rapamycin (mTOR) and STAT4 signaling pathways in activated NK cells. XBP1 facilitates NK cell expansion in part by directly binding to and activating the c-Myc promoter to upregulate key c-Myc target genes required for NK cell expansion as well as by controlling mitochondrial respiration. This study reveals an unexpected role for the IRE1α-XBP1 pathway and for the transcriptional regulator c-Myc in NK cell-mediated immunity. target genes (Supplementary Fig. 1a) . Consistent with this, transgenic ER stress-activated indicator (ERAI) reporter mice 19 revealed minimal IRE1α activation in naïve NK cells, but significantly elevated levels in activated NK cells at day 2 post-infection that returned to baseline by day 7 post-infection (Fig. 1b,c) indicating transient activation of this pathway in response to viral infection.
NK cell activation during viral infection occurs when exposed to cytokines, including IL-12 and IL-18, and ligation of activating receptors 4, 6, 20, 21 . Consistent with in vivo findings, RNA sequencing (RNA-seq) analysis of IL-12 and IL-18 in vitro-activated NK cells showed robust upregulation of the IRE1α-XBP1 UPR signature, Xbp1s induction and activation of canonical XBP1 target genes ( Fig. 1d and Supplementary Fig. 1b) . Results using the ERAI reporter mouse confirmed IRE1α activity in cytokine-activated NK cells from spleen and bone marrow (BM) (Fig. 1e) . Notably, XBP1 activation was also observed in primary human NK cells following IL-12 and IL-18 stimulation in vitro (Fig. 1f) .
We next identified both Stat4 and mTOR as upstream regulators of IRE1α-XBP1 function in infection and in cytokine-activated NK cells. STAT4
−/− NK cells displayed reduced Xbp1 and downstream target gene activation during MCMV infection ( Supplementary  Fig. 1c ) and pharmaceutical blockade of mTOR in NK cells significantly reduced IRE1α activation in response to cytokine stimulation in vitro ( Supplementary Fig. 1d ), consistent with mTOR induction of IRE1α-XBP1 function in liver, other organs and cell types [22] [23] [24] . Thus, IRE1α-XBP1 induction in NK cells is at least partially driven by both STAT4 and mTOR signaling pathways.
The UPR also activates the transcription factor Chop (encoded by Ddit3), a canonical ER stress marker that mediates ER stress responses. Notably, in contrast to MCMV activation of IRE1α-XBP1 in NK cells, MCMV infection repressed Ddit3 expression at day 1.5 post-infection compared to naïve NK cells (Fig. 1b and Supplementary Fig. 1a ) as did stimulation with IL-12 and IL-18 in vitro ( Fig. 1d and Supplementary Fig. 1b ). In contrast, NK cells treated with the pharmacologic ER stress inducer tunicamycin increased both Ddit3 and IRE1α-XBP1 activation ( Supplementary  Fig. 2a) . Hence, viral infection-driven NK cell activation selectively induces a limited or 'non-canonical' UPR restricted to the IRE1α-XBP1 branch.
Intrinsic requirement for IRE1α in NK cell antiviral immunity.
To determine if IRE1α-XBP1 activation in NK cells contributes to host protection against lethal viral infection, we generated mice with specific IRE1α ablation in NK cells (denoted as IRE1 NK mice) and IRE1α-deficient NK cells (henceforth denoted as IRE1 NK cells, Supplementary Fig. 2a-f ). MCMV-infected IRE1 NK were more susceptible to MCMV infection, with significantly increased viral titers and somewhat reduced overall survival (Fig. 2a,b ) than littermate control (IRE1 f/f ) mice (Supplementary Fig. 2a-d,f ). These data demonstrate that IRE1α is required for NK cell-mediated antiviral immunity.
Intrinsic requirement for IRE1α-XBP1 in NK cell expansion. Adaptive immune features of NK cells can contribute towards host protection against viral infection 25 . Ly49H-expressing NK cells recognize MCMV-infected cells and undergo a proliferative burst to enlarge the overall pool of effector cells, followed by a contraction of activated NK cells to form a long-lived population of memory NK cells 3 . To identify whether IRE1α promotes antiviral immunity of NK cells by regulating their adaptive traits, we co-transferred equal numbers of Ly49H + IRE1 NK and CD45.1 congenic wild type (WT) NK cells into Ly49H-deficient hosts and evaluated the ability of the transferred Ly49H + cells to expand following MCMV infection ( Fig. 2c and Supplementary Fig. 3a ). Whereas the transferred WT NK cells expanded robustly by day 7 post-infection, their IRE1 NK counterparts were dramatically reduced (Fig. 2d,e) . Moreover, the relative ratio of WT to IRE1 NK cells remained elevated throughout the time course, ruling out a delayed expansion of the IRE1 NK population (Fig. 2e) .
Reduction of IRE1 NK cells in peripheral blood was not due to selective aberrant trafficking, as similar deficiencies were found in spleen, liver, lung, BM and lymph nodes (Fig. 2f) Supplementary  Fig. 2b-d) . Transcriptome analysis revealed no change in expression of well-defined regulated IRE1-dependent decay (RIDD) of messenger RNA target genes ( Supplementary Fig. 4a ), indicating that IRE1α functions primarily via controlling its major substrate XBP1 rather than by RIDD. In contrast to the expansion defect, NK cell activation, cytokine production and cytotoxicity on a per cell basis was unaffected by deletion of IRE1α ( Supplementary Fig. 3b,c) . Levels of Akt-mTOR signaling were unchanged in IRE1 NK cells consistent with the placement of IRE1α-XBP1 downstream of mTOR ( Supplementary Fig. 3d ). We conclude that there is an essential cellintrinsic function for IRE1α-XBP1 to promote clonal expansion of NK cells during viral infection.
Control of NK cell proliferation but not survival by IRE1α-XBP1. To determine if IRE1α-XBP1 controls proliferation or survival/apoptosis in activated NK cells, we co-transferred Ly49H
NK and CD45.1 congenic WT NK cells labeled with a cell proliferation tracing dye into MCMV-infected Ly49H-deficient recipients and confirmed that IRE1α deficiency markedly impaired MCMVdriven proliferation in vivo (Fig. 3a-c) . Diminished proliferative capacity of IRE1 NK Ly49H + cells was corroborated by their reduced ability to incorporate EdU (5-ethynyl-2′-deoxyuridine) (Fig. 3d) .
IRE1
NK cells did not exhibit enhanced apoptosis, as determined by annexin V or activated caspases staining (Fig. 3e,f) . Hence, IRE1α is required for the proliferation but not survival of activated NK cells during viral infection.
Because IRE1α activation is induced to a similar extent in both antigen-specific Ly49H + and bystander Ly49H − (ref.
26
) NK cells during MCMV infection (Fig. 1c) , it was possible that IRE1α could regulate cytokine-driven NK cell proliferation independently of Ly49H-m157 engagement. Indeed, even adoptively transferred Ly49H − NK IRE1 NK cells showed impaired proliferation (Fig. 3c ), albeit to a lesser extent than MCMV-infected Ly49H + NK cells.
IRE1α-XBP1 drives NK cell homeostatic proliferation. Robust NK cell expansion can also be triggered by lymphopenia (homeostatic proliferation) 27 . Co-transfer of equal numbers of IRE1 NK and CD45.1 congenic WT splenic NK cells into lymphocyte-deficient (recipient Rag2 −/− Il2rg −/− mice) hosts (Fig. 4a) revealed that IRE1α deficiency leads to ~2.5-fold lower homeostatically driven NK cells (Fig. 4b ) due to decreased proliferation (Fig. 4c) . Thus, although IRE1α-XBP1 may be dispensable for NK cell development and basal homeostasis at steady state ( Supplementary Fig. 2b-f ), IRE1
NK cells exhibit dramatically compromised homeostatic proliferation during lymphopenia.
IL-2 and IL-15, cytokines of the common gamma chain family, expand 28, 29 and induce XBP1 splicing in NK cells ex vivo from mouse spleen, BM and human peripheral blood mononuclear cells (PBMCs) (Fig. 1e,f Fig. 4f,g ) although they expressed normal levels of these cytokine receptors ( Supplementary Fig. 2f ), ruling out hyposensitivity to cytokine signaling as the reason for their reduced proliferation. Additionally, pharmaceutical blockade of **** **** **** **** **** **** **** **** IRE1α activity using 4μ8C (ref. 30 ), the small molecule inhibitor of the IRE1α RNase domain, led to significant reduction in proliferation of primary human NK cells cultured in IL-2 and IL-15 ( Fig. 4h and Supplementary Fig. 4b ). Interestingly, 4μ8C primarily hindered the proliferation of CD56 bright NK cells (Fig. 4i) , a subset of human NK cells with higher proliferative capacity compared to CD56 dim counterparts 29 and consistent with a more robust induction of XBP1s protein in CD56 bright NK cell subsets (Fig. 4j) . Thus, the function of IRE1α-XBP1 in growth and proliferation is conserved between mouse and human NK cells. NK cells showed an overall transcriptome profile similar to their WT counterparts before infection, with 76 genes differentially expressed at day 0 (Fig. 5a) . Importantly, the gene expression profile of IRE1 NK cells at day 1.5 post-infection was markedly distinct from WT NK cells, with 897 genes differentially expressed (Fig. 5a ).
Activated immune cells undergo robust metabolic responses, key for regulating immune cell function and long-term fitness 32 . Activation of NK cell oxidative phosphorylation (OXPHOS) and glycolysis is essential for robust NK cell responses 33, 34 . Interestingly, oxidative phosphorylation (OXPHOS) was highlighted as the top downregulated cellular process in IRE1
NK cells by GO analysis (Fig. 5b,c) . Metabolic flux analysis on IL-12-and IL-18-activated human primary NK cells showed significantly decreased mRNA levels of OXPHOS signature and reduced maximal respiration rate upon blockade of IRE1α activity with 4μ8C ( Fig. 5d) . Consistent with this, electron microscopy revealed disrupted mitochondrial morphology on sorting-purified IRE1 NK cells during MCMV infection ( Supplementary Fig. 5 ). Collectively, the molecular, cellular and metabolic evidence suggests a critical role of IRE1α-XBP1 in supporting OXPHOS in NK cells. ) and IRE1α (gene name Ern1, top 6, P = 6.23
) were among the top upstream regulators in IRE1
NK cells providing validation ( Supplementary Fig. 6a) . Surprisingly, reduction of transcription factor Myc (N-Myc, top 2, P = 3.93
; c-Myc, top 5, P = 4.75
NK versus WT NK cells was predicted ( Supplementary Fig. 6a ) and the Myc signaling pathway was also identified by GO analysis (Fig. 6a) . Furthermore, we observed significantly reduced expression of Myc targets that control cell proliferation or processes highly related to cell growth in IRE1 NK cells (Fig. 6b) . Although Myc controls a range of biological processes, including cell growth, protein synthesis and cell metabolism 35, 36 , its importance in NK cell responses is less well studied 33 . Interestingly, although there is significant overlap between IRE1α-regulated and Myc-regulated genes identified in MCMV-primed NK cells ( Supplementary Fig. 6b ), Myc has not previously been described as a target of IRE1α-XBP1.
We investigated the kinetics of Myc expression in differentiating NK cells, and its potential correlation with IRE1α-XBP1 activation. N-Myc was undetectable in NK cells at all time points following MCMV infection, whereas basal levels of c-Myc mRNA were observed in naïve NK cells ( Supplementary Fig. 6c ). No appreciable expression of c-Myc protein was evident at baseline ( Supplementary  Fig. 6c ), attributed perhaps to c-Myc protein instability secondary to multiple degradation mechanisms 37 . Following MCMV infection, NK cells robustly upregulated c-Myc mRNA and protein levels were now easily detectable ( Supplementary Fig. 6c ). Furthermore, in MCMV-infected ERAI mice, levels of c-Myc protein correlated with IRE1α activity (Supplementary Fig. 6c ). These data suggest that engagement of both the IRE1α-XBP1 UPR and c-Myc are important during NK cell priming.
To test whether IRE1α-XBP1 is required for c-Myc induction, we measured c-Myc expression in IRE1 NK cells. The basal levels of c-Myc mRNA and protein were unaffected by the absence of IRE1α in naïve NK cells ( Supplementary Fig. 6d ). During MCMV infection, c-Myc transcript and protein levels were significantly diminished in IRE1 NK cells compared to WT counterparts (Fig. 6c-e) . Furthermore, suboptimal upregulation of canonical c-Myc-targeting genes was observed in IRE1 NK cells (Supplementary Fig. 6e ). Consistent with the notion that c-Myc acts as a transcriptional repressor of the cell cycle checkpoint protein p21 (ref. 38 ), mRNA levels of Cdkn2a were significantly upregulated by depletion of IRE1α (Supplementary Fig. 6e ). Because c-Myc expression was not completely eradicated in the absence of IRE1α, complementary upstream mechanisms probably exist (that is, mTOR, Supplementary Fig. 6h) . Induction of the c-Myc protein during homeostatic proliferation was also impaired in IRE1 NK cells (Supplementary Fig. 6i ). Together, these results indicate that IRE1α-XBP1 activation regulates c-Myc expression in NK cells.
XBP1 acts as a versatile transcription factor that facilitates adaptation to ER stress by regulating distinct sets of target genes involved in protein folding and quality control 9 . Putative XBP1-binding sites 39 were found in both human and mouse c-Myc promoter regions ( Supplementary Fig. 6f ). Chromatin immunoprecipitation (ChIP) assays performed on a mouse NK/ILC cell line (MNK-1) phenotypically and functionally similar to primary mouse NK cells 40 , and on two human NK cell lines derived from patients with aggressive NK leukemia/lymphoma (NKL 41 and KHYG-1; ref.
42
) revealed a robust enrichment of XBP1 binding to the c-Myc promoter region (Fig. 6f) . We also utilized a c-Myc reporter mouse strain (referred to as Myc GFP ) to assess the extent to which c-Myc promoter activation is dependent on IRE1α. Myc GFP NK cells were stimulated in vitro in the presence or absence of 4μ8C. Whereas c-Myc reporter GFP was induced upon treatment with either IL-15, or IL-12 and IL-18 in dimethylsulfoxide (DMSO)-treated control groups, GFP induction was largely impeded by IRE1α blockade (Fig. 6g ). Our data demonstrate that IRE1α positively regulates c-Myc transcription in activated NK cells by direct binding of XBP1 to the c-Myc promoter.
To evaluate c-Myc function in the expansion of activated NK cells, we generated mice that harbor NK cells with haploinsufficiency in c-Myc (referred to as Myc NK , Supplementary Fig. 7 (Fig. 5h) . Thus, c-Myc deficiency impairs clonal expansion of NK cells in a manner similar to NK cells lacking IRE1α or XBP1.
To formally test the hypothesis that IRE1α-XBP1 functions at least in part by regulating c-Myc in activated NK cells to facilitate their proliferation, we generated mice that harbor NK cells with (Fig. 7a) , although this conferred no appreciable advantage in proliferation during in vitro expansion (Fig. 7b-e) . We posited that if c-Myc is a primary mediator of IRE1α-XBP1 activity, then overexpression of c-Myc should restore NK cell proliferation when IRE1α is pharmaceutically blocked or genetically depleted. Indeed, we found that during in vitro expansion, NK cells from WT littermates (Myc fsf/+ Ncr1
Cre− ) had impaired proliferation after treatment with 4μ8C; however, NK cells from Myc OE mice were largely rescued from this defect and proliferated to a comparable extent as in the DMSO-treated control group (Fig. 7b) . Thus, the requirement of IRE1α-XBP1 for NK cell proliferation can be partially bypassed by moderate overexpression of c-Myc. We further crossed Myc OE with IRE1 NK mice to overexpress c-Myc in NK cells with genetic deletion of IRE1α. The delayed proliferation observed in IRE1 NK cells was significantly alleviated by restoration of c-Myc via genetic overexpression (Fig. 7c-e) . Collectively, these findings reveal a new XBP1-Myc axis that regulates NK cell expansion during infection and homeostatic proliferation.
Requirement for IRE1α-XBP1 in NK cell-mediated antitumor immunity. In addition to antiviral responses, NK cells play an essential role in the host antitumor response [43] [44] [45] [46] . The experimental intravenous B16 melanoma model provides a potent functional measurement of NK cell-mediated antitumor protection. Thus, we introduced B16F10 tumor cells intravenously to IRE1
NK and IRE1
f/f littermates. While the majority of IRE1 f/f mice were protected from lung tumor colonization at day 10 after inoculation, IRE1 NK mice exhibited significantly more melanoma nodules (Fig. 8a) and micrometastatic lesions (Fig. 8b) . Survival of melanoma-bearing IRE1 NK mice was significantly decreased and inversely correlated with the increased tumor burden (Fig. 8c) . Similarly to IRE1 NK mice, XBP1 NK mice also failed to control melanoma growth (Fig. 8d) , consistent with a role for XBP1 downstream of IRE1α in NK cells. Similar to the defect in expansion in IRE1 NK cells during viral infection, the lungs from tumor-inoculated IRE1 NK mice displayed a 50-70% reduction in percentages and absolute numbers of infiltrating NK cells compared to IRE1 f/f littermates' lungs ( Fig. 8e ) and significantly decreased levels of proliferation marker Ki-67 ( Fig. 8f) and transcription factor c-Myc (Fig. 8g) . Of note, the decreased number of NK cells and decreased levels of Ki-67 and c-Myc (Fig. 8e-g ) were only apparent following tumor injection, as no changes were detected in tumor-free animals ( Supplementary Figs. 8a and 2b ). These findings demonstrate that the IRE1α-XBP1 pathway is required for optimal NK cell expansion that facilitate host protection against NK cell-sensitive cancer.
Discussion
We demonstrate that the IRE1α-XBP1 branch of the ER stress response is a previously unrecognized key signaling pathway in NK cells essential for their function in viral infection, homeostatic proliferation and cancer. NK cells lacking either the upstream sensor IRE1α or its downstream substrate XBP1 fail to expand in response to MCMV infection, lymphopenia or melanoma. Mechanistically, IRE1α-XBP1 directly regulates c-Myc signaling and mitochondrial respiration to control NK cell proliferation. Hence the mammalian immune system has evolved a mechanism to incorporate a common cellular stress process to enhance antiviral immunity. The fact that this conserved pathway is co-opted by pathogens to ensure their survival in host cells 47 provides intriguing evidence for host-virus coevolution.
The host immune system controls viral infection primarily through early activation of innate NK cells followed by adaptive responses by CD8 + cytotoxic T cells. NK cells recognize infected cells without prior sensitization to counteract infection by initiating effector functions, including cytotoxicity, cytokine production and proliferation 7 . However, less is known about the intrinsic regulators that control their function or expansion 5, 6 . Here we identify the ER stress response as an essential driver of NK cell expansion in vivo during MCMV infection. Cytomegalovirus (CMV) is a leading cause of birth defects in newborns and a dangerous pathogen in immunocompromised individuals (including patients with cancer and transplants). No effective vaccine against CMV is available 48 . We demonstrate that human primary NK cells activate IRE1α-XBP1 in response to pro-inflammatory cytokines present during CMV infection and rely on this pathway for optimal ex vivo expansion. IRE1α activation may help develop new vaccine strategies for host control of pathogens by strengthening NK cell responses.
In patients and in animal models, impaired NK cell function is associated not only with recurring viral infection, but also with an increased incidence of various malignancies 7, 49, 50 . NK cells whose 'primed' cytotoxicity is elicited by activating receptor signaling 51, 52 , and their ability to recruit other immune cells into the tumor microenvironment 46 , play a pivotal role in cancer immunosurveillance. The failure to control melanoma lung metastasis is associated with impaired expansion of the NK cell compartment, providing the first in vivo indication that IRE1α-driven NK cell expansion is critical for tumor immunosurveillance. The deficiency in NK cell expansion correlates with reduced recruitment of type 1 conventional dendritic cells and CD8 + T cells, consistent with the notion that NK cells not only function as direct killers, but also potentiate an antitumor microenvironment 46 . Future studies should investigate whether IRE1α-XBP1 represents the major signaling pathway that drives NK cell expansion in additional malignancies and to assess whether and to what extent other known regulators of NK cell expansion, such as Zbtb32 (ref. 5 ), Runx1/3 (ref. 6 ) and IRF8 (ref. 53 ), also contribute to halting tumor growth.
NK cells have recently attracted attention for their potential use as immune-based therapies 51, 52, [54] [55] [56] , best documented in the setting of hematopoietic cell transplantation (HCT) in patients with leukemia 43 . Alloantigen-specific NK cells can benefit such patients by providing graft-versus-tumor function, while preventing T cellmediated graft-versus-host disease 44 . Patients with leukemia undergoing immunoablative treatments before HCT often become susceptible to CMV 48 , highlighting the key role of NK cells in eliminating both tumor and virus. In addition, NK cells are the first lymphocytes to reconstitute the BM of patients following HCT 43 . However, the magnitude of and mechanism underlying NK cell homeostatic proliferation in the setting of lymphopenia are poorly understood 3, 27, 57 . We demonstrate that, although unnecessary for normal NK cell expansion during development, IRE1α-XBP1 is indispensable for the homeostatic proliferation of mature NK cells in vivo in response to lymphopenia-induced stress, and for IL-15-driven homeostatic-like proliferation of human primary NK cells largely provided by the CD56 bright highly proliferative subset. Our findings provide justification for incorporating NK cells into adoptive cellular immunotherapies to target cancer in patients following immunoablative treatment 7, 50 , and suggest that pre-treatment of NK cells with a combination of cytokines (for instance, IL-15, IL-12 and IL-18 that are now being used in the clinic) might further increase the therapeutic efficiency of adoptive NK cell transfer. As this paper was being revised after peer review, it was reported that XBP1 is important in vitro for IL-15-driven human NK cell function 58 . By using engineered genetic mouse models, our study demonstrates an essential in vivo requirement of the IRE1α-XBP1 pathway in NK cell-mediated antitumor and antiviral protection, and identifies cellular and molecular mechanisms of action. Future studies should test the feasibility and efficacy of utilizing genetically manipulated IRE1α-XBP1-overexpressing 'adaptive' NK cells to treat a variety of liquid or solid malignancies.
In sharp contrast to its protective role in activating NK cell immunity against CMV and melanoma described herein, overactive IRE1α-XBP1 in dendritic cells 17 and CD4 + T cells 16 through Toll-like receptor signaling, while in NK cells, as shown here, both IL-12-STAT4 and mTOR act as critical upstream regulators of IRE1α-XBP1 under infectious/inflammatory conditions. Indeed, mTOR is also situated downstream of IL-15 (refs. 28, 59 ) and IL-12 (ref. 33 ) and is essential for NK cell development and antitumor responses 60 . A recent publication demonstrated that mTOR drives NK littermates at day 10 following intravenous injection of B16F10 melanoma. Quantification of total extrapulmonary metastatic nodules is shown on the right. n = 10 mice per group. b, H&E microscopic analysis of lungs from IRE1 f/f and IRE1 NK mice described in a. c, Survival curve of B16F10-inoculated IRE1 f/f (n = 11) and IRE1 NK (n = 14) mice described in a. d, Similarly as in a, quantification of total extrapulmonary metastatic nodules from XBP1 f/f and XBP1 NK littermates at day 20 following intravenous injection of B16F10 melanoma. n = 8 mice per group. e-g, Flow cytometry analysis of lungs from B16F10 tumorinoculated mice described in a. Graphs shown are percentage of NK cells in total lymphocyte population and the absolute numbers (n = 8 for IRE1
f/f , n = 9 for IRE1 NK ) (e), Ki-67 (n = 6 mice/group) (f) and c-Myc expression (n = 6 mice per group) (g) in lung-infiltrated NK cells. Each symbol is a different mouse (a,d-g). All error bars represent mean with s.e.m. **P < 0.01, ***P < 0.001, ****P < 0.0001. Data were analyzed by two-tailed Mann-Whitney U-test (a,d,e-g) or two-tailed log-rank test (c). Data are representative of two independnet experiments (b,f,g), or pooled from three (a) or two experiments (c-e).
IRE1α-XBP1 activation in liver in response to food perception 22 , as well as in lung T H 2 cells and fibroblasts in fibrotic disease 23, 24 . We also report the unexpected finding that XBP1 directly controls the transcription of c-Myc and its downstream target genes in NK cells. This may appear paradoxical in light of the recent finding that the oncogene c-Myc acts upstream of the IRE1α-XBP1 pathway to drive tumorigenesis 61 . However, this discrepancy may be explained by the differing functions and downstream consequences of IRE1α signaling in normal versus transformed cells. One clear difference between transformed versus normal cells is that the former are addicted to constitutively activated c-Myc, while the latter display negligible levels of c-Myc at baseline, requiring external stimuli to be induced. Although c-Myc is among the best-studied oncogenes, and tumor-intrinsic c-Myc activity can program an immune suppressive microenvironment obligatory for tumor progression 62 , its function in immune cells is less well understood 63 . c-Myc is essential for metabolic responses in IL-2 and IL-12-activated mouse NK cells ex vivo 33 . In human NK cells ex vivo, c-MYC functions downstream of IL-15 to enhance effector function 64 . Here, we provide the in vivo evidence of an essential role for c-Myc acting downstream of IRE1α-XBP1 to drive NK cell expansion during MCMV infection, lymphopenia and antitumor immunity. Indeed, c-MYC levels were noted to be significantly decreased in NK cells from patients with cancer compared to healthy donors 65 , suggesting a protective role of c-MYC in NK cell-mediated antitumor immunity in patients.
Finally, our finding that IRE1α supports mitochondrial function and morphology in NK cells was unexpected given that we have recently described that depletion of IRE1α-XBP1 helps to restore the metabolic fitness of T cells in ovarian cancer 16 . Intriguingly, 25 of the 46 differentially expressed OXPHOS genes in IRE1α-deficient NK cells are known to be regulated by c-Myc 35 . Thus, the dysregulated metabolism observed here may be in part a consequence of impaired Myc signaling 33 , which is in turn at least partly responsible for the failure of IRE1α-deficient NK cells to expand appropriately in vivo in response to viral infection, lymphopenia and malignancy.
In conclusion, our study reveals an essential function for the ER stress sensor IRE1α and its downstream substrate XBP1 to drive NK cell expansion that results in effective responses against viral infection and tumors. IRE1α activation is situated downstream of both the Stat4 and mTOR signaling pathways and upstream of c-Myc. Like c-Myc, IRE1α-XBP1 also promotes OXPHOS in NK cells. We have identified a IRE1α-XBP1-cMyc axis in NK cell immunity, required for host protection against infection and cancer.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41590-019-0388-z. Virus infection. MCMV (Smith strain) was passaged serially through BALB/c hosts two times, then viral stocks were prepared by using a Dounce homogenizer to dissociate the salivary glands of infected mice 3 weeks after infection. For direct infection of C57BL/6 or ERAI mice, 7.5 × 10 3 plaque-forming units (PFU) of MCMV were injected intraperitoneally. For the adoptive transfer studies, Ly49-deficient mice were infected by intraperitoneal injection of 7. 
CD3
− TCRβ − F4/80 − NK1.1 + cells. All analysis was performed on viable populations by exclusion of the dead cells using a fixable viability dye (Thermo Fisher). For the evaluation of NK cell apoptosis, Pan-caspase (FLICA) staining was carried out using the FAM FLICA in vitro Poly Caspase Kit (Immunochemistry Technologies) per the manufacturer's protocol; annexin V staining was carried out using the Invitrogen eBioscience Annexin V Apoptosis Detection Kit per the manufacturer's instructions. For the evaluation of NK cell proliferation, cells were labeled with 5 μM CTV (Invitrogen) according to the manufacturer's protocol before transfer into recipient mice; intracellular staining of Ki-67, c-Myc and XBP1s was performed by fixing and permeabilizing with the Foxp3/Transcription Factor Staining Kit (eBioscience); for the EdU labeling experiments, mice were subjected to intraperitoneal injection of 1.5 mg of EdU in PBS on days 3.5 after infection with MCMV, and EdU labeling was determined ~16 h later using the Click-iT EdU Assay Kit (Thermo Fisher Scientific). Flow cytometry was performed on the LSR II (BD Biosciences), LSR Fortessa X-20 and CytoFLEX LX (Beckman Coulter) machines. Cell sorting was performed on Aria II cytometers (BD Biosciences). For experiments involving quantitative real-time PCR (qrtPCR), cell populations were sorted to >95% purity. Data were analyzed with FlowJo software (Tree Star). ; eBioscience) re-applied every other day. In some assays indicated, 5 μM of 4μ8C (IRE1α inhibitor; Sigma Aldrich) was added to the culture and DMSO was used as the control treatment.
PBMCs from healthy donors (New York Blood Center) were isolated by density gradient centrifugation with Ficoll (GE Healthcare). NK cells were enriched by negative selection using the human NK Cell Isolation Kit (Miltenyi Biotec; >90% purity). For ex vivo stimulation in Fig. 1f, ~10 6 sorted primary human NK cells were stimulated for 16 h in complete RPMI containing 10% FBS with recombinant human IL-2 (10 ng ml ; StemCell) were applied. Fresh medium and cytokines were added on alternating days of culture. In some assays indicated, 4μ8C (IRE1α inhibitor, 5 μM or lower) was added to the culture and DMSO was used as the control treatment. For flow cytometric analysis or cell sorting, human NK cells were defined as CD3 − CD56
+ .
NK cell lines and culture conditions. MNK-1 cells 40 were cultured in DMEM supplemented with 10% FBS, 2 mM GlutaMAX, 1 mM sodium pyruvate, 55 μM 2-mercaptoethanol, 10 mM HEPES, 50 μg ml −1 gentamicin, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin (all from Corning or Gibco Life Technologies, except FBS from Atlanta Biologicals). To facilitate robust survival, 10 ng ml −1 recombinant mouse IL-2 (BioLegend) were re-applied daily. NKL cells 41 and KHYG-1 cells 42 were cultured in RPMI 1640 medium supplemented with 2 mM l-glutamine, 1 mM sodium pyruvate, 100 U ml −1 penicillin, 100 μg ml −1 streptomycin and 7.5% FBS plus 7.5% newborn calf serum (all from Corning or Gibco Life Technologies, except FBS from Atlanta Biologicals). The cell concentration was maintained at ~5 × 10 5 cells per ml in the presence of 50 U ml −1 of recombinant human IL-2 (Amgen). All cell lines routinely tested negative for mycoplasma contamination using the Mycoplasma Detection Kit (Lonza) and were maintained in medium containing plasmocin (Invivogen) for prophylactic purpose.
Quantitative real-time PCR. Cells were pre-enriched (Miltenyi Biotec) and then sorted to >95% purity and RNA was isolated using the RNeasy RNA purification mini (for 5 × 10 5 cells or beyond) or micro (for <5 × 10 5 cells) kit (Qiagen) according to the manufacturer's protocol. From purified RNA, complementary DNA was synthesized using the reverse-transcriptase kit qScript cDNA synthesis kit (Quanta Biosciences). qrtPCR was performed in triplicates in a 384-well plate using Taqman Probes (Themo Fisher) or SYBR Green (Quanta Biosciences)-based detection on an ABI QuantStudio 6 Flex qrtPCR machine. For experiments in Fig. 6c , CellDirect One-Step qrtPCR Kit with Rox (Life Technologies) was used according to the manufacturer's instruction. For the analysis of mRNA abundance, the derived values were normalized to those of β-Actin (β-ACTIN for human materials). Primer sequences are in Supplementary Table 1 and Taqman probe  information is in Supplementary Table 2. RNA-seq analysis. Mixed IRE1 NK (CD45.2): WT (CD45.1) BM chimeric mice were generated as previously described 31 . Briefly, host C57BL/6 × B6.SJL animals (CD45.1 
CD45.2
+ host NK cells were excluded from all analyses. Mice were infected with 7.5 × 10 3 PFU of MCMV by intraperitoneal injection and spleens were collected at day 0, 1.5 and 7 after infection. Total RNA from sorting-purified Ly49H + WT or IRE1 NK NK cells was extracted with the RNeasy RNA purification micro kit (Qiagen) according to the manufacturer's instructions. Poly(A) + RNA-seq libraries (pair-end 100) were prepared with an Illumina TruSeq RNA Sample Preparation Kit v.2 according to the manufacturer's instructions (Illumina). Sequence data from Illumina's HiSeq4000 sequencer were 'de-multiplexed' to generate FASTQ files for each sample with Illumina's CASAVA pipeline (v.1.8.2).
The reads that passed Illumina's quality and purity filter (>90%) were aligned to the mouse genome (Illumina iGenomes mm9 build) with tophat2 (ref. 68 ) with default parameters. The resulting SAM alignment files were then converted to the BAM file format, then were sorted and indexed with SAMtools (v.0.1.14). The HTSeq 69 was used for summarization of the aligned sequence reads into counts. Differential gene expression was analyzed with the DESeq2 (ref. 70 ). Transcripts with adjusted P value < 0.01 were considered differentially expressed between genotypes (WT and IRE1 NK ) and infection times (day 0, 1.5, 7). Gene ontology analysis of differentially expressed genes was performed in gene-set enrichment analysis (GSEA) 71 . Pathway analysis of predicted upstream regulators was performed with Ingenuity Pathway Analysis software (Qiagen). For heat maps, normalized data from DESeq RNA-seq analyses were exported, manually curated for specific genes in each category and the gene expression z score was visualized with the Heatmap.2 function within the gplots R library.
Chromatin immunoprecipitation. MNK-1, NKL and KHYG-1 cells were crosslinked with 1% formaldehyde for 10 min at room temperature. Reaction was quenched with 125 mM glycine. ChIP was performed as previously described with XBP1 antibody (catalog no. 619502, Biolegend) or normal rabbit IgG control (catalog no. 2729, CST). The sequences of all primers are listed in Supplementary Table 3 .
Immunoblots. Sorted-purified NK cells (purity >97%) from WT: IRE1 NK mixed BM chimeras day 1.5 post-infection were collected directly into 20% trichloroacetic acid buffer. After sorting, the concentration of trichloroacetic acid was adjusted to 10% before incubation on ice for 30 min to precipitate proteins. The homogenates were centrifuged at 13,000 r.p.m. for 10 min at 4 °C, and the supernatant was carefully removed. The pellets with concentrated proteins were washed twice with acetone and then solubilized in solubilization buffer (containing 9 M urea, 2% Triton X-100 and 1% dithiothreitol) mixed with LDS buffer (Invitrogen). The samples were heated at 70 °C for 10 min and protein concentrations determined using a BCA protein assay kit (Thermo Fisher Scientific). Equivalent amounts of protein for WT and KO cells from the same BM chimeras were separated by SDS-PAGE (Bis-Tris gel, Invitrogen) and transferred onto polyvinylidenedifluoride membranes following the standard protocol. Anti-cMyc (D84C12, Cell Signaling Technology), anti-β-Actin (Cell Signaling Technology) and goat anti-rabbit secondary antibodies conjugated wiih HRP (Thermo Fisher Scientific) were used. SuperSignal West Pico and Femto chemiluminescent substrates (Thermo Fisher Scientific) were used to image blots in a ChemiDoc MP Imaging System instrument (BioRad). Densitometric quantification was performed using ImageJ software (National Institutes of Health, NIH).
Metabolic flux assays.
Purified human primary NK cells from healthy PBMC donors were stimulated with human recombinant IL-12 and IL-18 for 16 h in complete RPMI medium, in the presence or absence of IRE1 inhibitor 4μ8C (5 μM). After incubation, NK cells were collected, thoroughly washed and then subjected to Seahorse analyses using non-buffered XF base medium containing 25 mM glucose, 2 mM l-glutamine and 1 mM sodium pyruvate, but lacking serum. XF96 cell-culture microplates were coated with CellTak (Corning) before analysis according to the manufacturer's instructions and washed twice with distilled water. NK cells (6 × 10 5 ) were plated and OCR measurements were analyzed on an XFe96 Extracellular Flux Analyzer (Agilent). After basal oxygen consumption rate (OCR) measurements were obtained, an OCR trace was recorded in response to oligomycin (1 μM), carbonyl cyanide-p-(trifluoromethoxy) phenylhydrazone (FCCP, 1 μM), and rotenone and antimycin (0.5 μM each) following the XF Cell Mito Stress test kit (Agilent). Metabolic parameters were calculated as follows: basal OCR = last rate measurement before oligomycin injection − minimum rate measurement after rotenone and antimycin injection; maximal OCR = maximum rate measurement after FCCP injection − minimum rate measurement after rotenone and antimycin injection. Typically, 3-6 technical replicates for each sample were examined. OCR values were normalized by protein input amount accordingly.
Experimental melanoma lung metastasis. B16F10 cells 73 were cultured in DMEM supplemented with 10% FBS, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin. B16F10 cells (2.0 × 10 5 ) were injected intravenously through the tail vein. Mice were killed and lungs were collected on day 10-20 post-inoculation. Lung tumor nodules were enumerated by gross count of visible sites of disease. Micrometastatic lesions were identified using hematoxylin and eosin (H&E) stained lung sections. All pulmonary tumor measurements were performed in a blinded manner. For the flow cytometric analysis, mice received an intravenous injection of fluorescenceconjugated anti-CD45.2 3 min before euthanasia to label intravascular immune cells that would be excluded from downstream analysis. Lungs were collected from tumor-bearing mice following euthanasia by CO 2 inhalation, and single-cell suspensions were obtained using a gentleMACS dissociator (Miltenyi Biotec), per manufacturer's instructions.
Statistics. For graphs, data are shown as mean ± s.e.m. or s.d. as indicated and, unless otherwise indicated, statistical differences were evaluated using a two-tailed unpaired Student's t-test, assuming equal sample variance. P < 0.05 was considered significant. Graphs were produced and statistical analyses were performed using GraphPad Prism or R. Sample size was not specifically predetermined, but the number of mice used was consistent with prior experience with similar experiments.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The RNA-seq data were deposited in the Gene Expression Omnibus under the accession number GSE113214. The remaining data that support the findings of this study are available from the corresponding authors upon request. Materials will be provided with material transfer agreements in place as appropriate.
